Squeeze AMIX
AMIX (Autonomix Medical) – Low-Float Squeeze Watch
Updated August 24, 2026 (After-Hours)
This post is for informational and educational purposes only. It is not financial advice, investment advice, or a recommendation to buy, sell, or hold any security. Trading micro-cap and low-float stocks involves extreme risk of loss, including the possibility of losing your entire investment. Past performance is not indicative of future results. Always do your own due diligence and consult a licensed financial advisor. The author and any sources cited have no obligation to update this information.
Ticker: AMIX | Exchange: NASDAQ | Company: Autonomix Medical, Inc.
View Live Chart on TradingView →
Quick Snapshot (as of late August 24, 2026)
| Metric | Detail |
|---|---|
| Approximate Price (AH) | Spiking from the mid-$5s into the $10–$11+ range after hours |
| Shares Outstanding | ~971,000 |
| Float (approx.) | ~940,000 – 955,000 (sub-1 million) |
| Short Interest (July 31 settlement) | ~263,400 shares |
| Short % of Float / Outstanding | Roughly 27%–50% depending on exact float figure used by source |
| Days to Cover | ~1 (elevated recent volume) |
| Cost to Borrow (CTB) | Extremely high – recently 680%–880% range |
| Shares Available to Borrow | Very tight (often near zero to only a few hundred/thousand) |
| Market Cap (approx.) | Low single-digit millions (highly sensitive to price moves) |
| 52-Week Range | $2.44 – $32.55 |
What Is Driving the Move Today?
After-hours on August 24, 2026, AMIX experienced a sharp squeeze-style spike. Multiple traders on X noted the stock moving from the mid-$5s into double digits on the news that Autonomix Medical is scheduled to be granted U.S. Patent No. 12,714,780 on August 25, 2026.
Patent title: “Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.”
This continues a pattern of strong reactions to intellectual-property announcements for the company earlier in the month.
Why Traders Are Watching It as a Squeeze Candidate
- Sub-1 million float after the 1-for-21 reverse split in June 2026
- Meaningful short interest relative to the tiny float
- Extremely elevated cost-to-borrow and limited shares available to short
- History of violent multi-hundred-percent moves on volume and news
- Active discussion among low-float / momentum traders
Trader Sentiment Snapshot (X / Twitter – August 24)
Popular low-float and momentum accounts were actively commenting in real time as the after-hours move developed:
- Multiple traders (including accounts frequently followed in the low-float community) noted the combination of tiny float + high CTB as the primary fuel.
- Several accounts reported scalping the move multiple times on the way up.
- Some traders flagged that these types of moves often fade once volume dries up, and highlighted ongoing dilution / cash-runway concerns.
- Patent news was widely cited as the immediate catalyst for the afternoon/evening spike.
Note: Social media commentary is highly anecdotal, often lagging or promotional, and should never be treated as research.
Key Risks (Do Not Ignore)
| Risk | Description |
|---|---|
| Dilution | Recent warrant inducements and share registration filings create ongoing overhang. |
| Cash Runway | Company is development-stage with limited cash and ongoing burn. |
| Volatility | Can give back large percentages of gains in a single session once momentum fades. |
| Liquidity | Even with elevated volume, spreads and slippage can be significant. |
| Fundamentals | No meaningful revenue; pure clinical / IP story at this stage. |
Useful Links
Low-float stocks like AMIX can move 50–300%+ in either direction with little notice. This is speculative trading, not investing. Position size accordingly, use stops if that fits your process, and never risk money you cannot afford to lose. Nothing in this post constitutes a trade recommendation.
Comments
Post a Comment